VYGR Voyager Therapeutics Inc
Company Analysis
Latest News
🟢 Voyager Therapeutics is trading 5.25% up today amid broader biotech sector strength
Voyager Therapeutics is trading at $3.21 (+5.25%) in pre-market sessions as the stock gains momentum despite a lack of fresh company-specific announcements. •...
🔴 Voyager Therapeutics is trading 5.5% down today as risk-off sentiment hits biotech sector
Voyager Therapeutics is trading 5.5% down at $3.02 as risk-off sentiment pressures the biotech sector and broader markets. • The decline extends a multi-day...
Voyager Presents Favorable Preclinical Data for Alzheimer's Gene Therapy Candidate VY1706
Voyager Therapeutics announced positive good laboratory practice (GLP) toxicology data for VY1706, its investigational tau silencing gene therapy for...
🔴 Voyager Therapeutics is trading 5.2% down today as risk-off sentiment pressures the biotech sector
Voyager Therapeutics is trading 5.2% down at $3.26 as risk-off sentiment hits the biotech sector, extending a multi-session slide from recent highs. • The...
🔴 Voyager Therapeutics is trading 5.4% down today with no clear catalyst
Voyager Therapeutics is trading 5.4% down at $3.48 amid light company news flow and a generally mixed broader market backdrop. • The stock's move appears tied...
🟢 VYGR is trading 5.3% up today following recent FDA IND clearance for VY1706 and upcoming AAIC presentation
• Voyager Therapeutics (VYGR) is trading 5.3% up today at $3.81. • The company recently received FDA Investigational New Drug (IND) clearance for VY1706, its...